期刊文献+

不具备PCI条件的医疗机构对STEMI患者再灌注治疗的处理策略 被引量:3

Reperfusion strategy for patients with ST-segment elevation myocardial infarction in hospitals without PCI facility
下载PDF
导出
摘要 对于不具备介入条件的医疗机构,溶栓仍是处理ST段抬高型急性心肌梗死(STEMI)的重要措施。然而,对于STEMI患者溶栓后应该采取怎样的后续处理目前仍无定论。过去认为溶栓后应尽量采取保守治疗,《经皮冠状动脉介入治疗指南(2009)》也提出溶栓成功后应依据缺血与否对患者进行评估,然后决定是否转运行经皮冠状动脉介入治疗(PCI),但是支持这一观点的循证医学证据不足。近年来的几项临床研究结果提示,STEMI患者无论溶栓成功与否,对于不具备PCI条件的医院,立即转运行PCI可能是降低患者主要心血管事件发生率的最合适的方法。 Thrombolysis is still an important treatment modality in patients with ST-segment elevation myocardial infarction (STEMI) in a hospital without percutaneous coronary intervention (PCI) facility. However, the optimal treatment after thrombolysis is still unclear. Conservative treatment after thrombolysis was recommended in the past. "Guidelines for percutaneous coronary intervention (2009)" also suggested that the condition of STEMI patients should be evaluated to determine whether the patient should be transferred to a hospital with PCI facility. But this suggestion lacksed evidence-based support. In recent years, several clinical trials suggested that immediate transfer to the nearest interventional centre for PCI was plausible regardless of success or failure in thrombolysis in local hospital, and this might reduce the incidence of cardiovascular events in patients with STEMI.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第5期496-498,共3页 Medical Journal of Chinese People's Liberation Army
关键词 心肌梗死 心肌再灌注 血管成形术 经腔 经皮冠状动脉 myocardial infarction myocardial reperfusion angioplasty transluminal percutaneous coronary
  • 相关文献

参考文献13

  • 1Verheugt FW. Routine angioplasty after fibrinolysis--how early should "early" be[J]? N Engl J Med, 2009, 360(26) : 2779-2781.
  • 2Simoons ML, Arnold AE, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty[J]. Lancet, 1988, 1(8579): 197-203.
  • 3Cantor WJ, Brunet F, Ziegler CP, et al. Immediate angioplasty after thrombolysis: a systematic review[J]. CMAJ, 2005, 173(12):1473-1481.
  • 4Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-fadlitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI) : randomised trial[J]. Lancet, 2006, 367(9510): 569-578.
  • 5Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction[J]. N Engl J Med, 2008, 358(21): 2205-2217.
  • 6Widirnsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study[J]. Eur Heart J, 2000, 21(10): 823-831.
  • 7Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute mycc.ardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2[J]. Eur Heart J, 2003, 24(1): 94-104.
  • 8Widimsky P, Bilkova D, Penicka M, et al. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow- up of the PRAGUE-2 Trial[J]. Eur Heart J, 2007, 28(6): 679-684.
  • 9Busk M, Maeng M, Rasmussen K, et al. The Danish multicentre randomized study of fibrinolytic therapy va primary angioplasty in acute myocardial infarction (the DANAMI-2 trial) : outcome after 3 years follow-up[J]. Eur Heart J, 2008, 29(10) : 1259-1266.
  • 10Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI) : an open, prospective, randomised, multicentre trial[J]. Lancet, 2008, 371(9612) : 559-568.

同被引文献19

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部